₹273.80
+0.20%NSE close, 16 Nov 2026
−5.47%
Health X Platform is a small cap company, listed on NSE under the symbol HEALTHX. At ₹273.80 a share, the market values the whole company at ₹871 crore.
In FY26, it reported revenue of ₹1,319 crore and a net profit of ₹1 crore.
The market values the company at 1.38 times its book value; its return on equity is -2.9%.
Promoters hold 74.07% of the shares. Foreign institutions hold 2.32%, and domestic institutions, mutual funds among them, 2.61%.
Over the past year the share price has fallen 5.5%, and it is 24.6% below its 52-week high.
Built for companies that make and sell things. Banks and lenders borrow and lend as their business, so these are left out for them: see return on assets and net margin under Profitability.
Built for companies that make and sell things. Banks and lenders borrow and lend as their business, so these are left out for them: see return on assets and net margin under Profitability.
Built for companies that make and sell things. Banks and lenders borrow and lend as their business, so these are left out for them: see return on assets and net margin under Profitability.
₹ crore. Consolidated figures.
Link of Recording
The financial results for the period ended September 30, 2026.
Intimation of Schedule of the Earnings Conference Call for Q2 of FY2026-27 and registration Link thereof
A copy Srutinizers report of Annual General Meeting held on September 28, 2026. Further, the company has informed the Exchange regarding voting results.
Proceedings of Annual General Meeting held on September 28, 2026
| Mar 2026 |
|---|
| Jun 2026 |
|---|
| Sep 2026 |
|---|
| Revenue | 375 | 307 | 270 | 274 | 281 | 286 | 298 | 301 | 346 | 374 | 447 | 484 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Finance costs | 0.2 | 0.3 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.2 | 0.5 | 0.6 | 0.9 |
| Total expenses | 374 | 320 | 274 | 280 | 306 | 312 | 294 | 325 | 358 | 401 | 458 | 510 |
| Profit before tax | 21.0 | 5.0 | 24.6 | −174 | −39.2 | −4.6 | 30.2 | −18.6 | 0.9 | −14.8 | 2.0 | −15.2 |
| Tax | 0.8 | −29.2 | −25.3 | −22.9 | 0.8 | −22.2 | 3.6 | −3.2 | 0.6 | −1.9 | −0.0 | −2.5 |
| Net profit | −0.8 | 16.4 | 31.2 | −109 | −26.9 | 13.7 | 23.9 | −12.7 | 1.1 | −11.2 | 2.5 | −11.0 |
| EPS (₹) | -0.23 | 5.17 | 9.79 | -34.40 | -8.47 | 4.30 | 7.52 | -3.99 | 0.35 | -3.51 | 0.80 | -3.47 |
₹ crore, financial years to March.
| Line | FY20 | FY21 | FY22 S | FY23 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Revenue | 385 | 548 | 0 | 1,040 | 1,111 | 1,319 |
| Finance costs | 0.7 | 1.1 | 0.0 | 0.9 | 0.2 | 0.8 |
| Total expenses | 446 | 568 | 1.3 | 1,093 | 1,173 | 1,379 |
| Profit before tax | −57.6 | −16.4 | −0.3 | −37.4 | −193 | −2.4 |
| Tax | −5.4 | 0.7 | 0.1 | −8.7 | −70.1 | −0.9 |
| Net profit | −38.8 | −10.4 | −0.4 | −82.4 | −91.2 | 1.2 |
| EPS (₹) | -12.20 | -3.27 | -0.12 | -25.90 | -28.66 | 0.37 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY22 | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|---|
| From operations | −4.5 | −17.3 | −73.8 | −67.1 |
| From investing | 4.5 | −1.1 | 171 | 46.6 |
| From financing | 0 | −0.4 | −79.6 | 6.4 |
| Spent on fixed assets | −0.1 | −10.4 | −14.9 | −12.4 |
| Free cash flow | −4.6 | −27.7 | −88.8 | −79.5 |
Margins, returns, debt, tax and cash.
| Line | FY20 | FY21 | FY22 | FY23 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Net margin | -10.1% | -1.9% | – | -7.9% | -8.2% | 0.1% |
| Operating margin | -14.4% | -2.6% | – | -4.2% | – | – |
| Return on equity | – | – | – | -8.3% | -13.6% | 0.2% |
| Return on assets | – | – | – | -6.8% | -9.4% | 0.1% |
| Debt to equity | – | – | – | 0.00 | – | – |
Dispatch of letter to shareholders whose e-mail addresses are not registered with the Company or RTA or Depository Participants' - under Reg 30 and Reg 36(1)(b) of SEBI LODR Reg..
Business Responsibility and Sustainability Report of the Company for the FY 2025-26
Notice of Annual General Meeting to be held on September 28, 2026 at 3.00 PM (IST)
Intimation regarding the 37th Annual General Meeting of the Company
Schedule of meet
Transcript
Change in Management - Re-appointment of Mrs. Anjana Dikshit (DIN - 10377490) as an Independent Director for a second term of 5 (five) consecutive years
The Outcome and Board Meeting and Unaudited financial results for the period ended Jun 30, 2026.